Sanofi Collaborates With German Biotech Company to Develop a New Class of Diabetes Drugs

by Reshma Anand on  August 7, 2015 at 4:54 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

Sanofi collaborates with Evotec AG, a german biotech company to develop a new class of medicines to treat diabetes. Its focus is on developing a beta cell replacement therapy based on functional human beta cells derived from human stem cells.
 Sanofi Collaborates With German Biotech Company to Develop a New Class of Diabetes Drugs
Sanofi Collaborates With German Biotech Company to Develop a New Class of Diabetes Drugs

The collaboration will use human stem cells to develop drugs that bolster "Beta" cells, which release insulin and become impaired in people with diabetes. The drugs could reduce the need for diabetes patients to inject themselves with insulin, said Sanofi.

Sanofi could pay Evotec up to EUR300 million ($327.8 million) for hitting various drug development milestones, plus additional royalties on different drugs.

The collaboration will further enhance and complement Sanofi's extensive diabetes portfolio and will extend Evotec's metabolic disease and stem cell-based drug discovery programs.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...